Vigil Neuroscience, Inc.
NASDAQ:VIGL
Overview | Financials
Company Name | Vigil Neuroscience, Inc. |
Symbol | VIGL |
Currency | USD |
Price | 2.73 |
Market Cap | 111,600,997 |
Dividend Yield | 0% |
52-week-range | 1.49 - 6.06 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Ivana Magovcevic-Liebisch J.D., Ph.D. |
Website | https://www.vigilneuro.com |
An error occurred while fetching data.
About Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2)
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD